30
Participants
Start Date
April 30, 2013
Primary Completion Date
December 7, 2016
Study Completion Date
March 4, 2017
Intra-Articular Hyaluronic Acid-Euflexxa
IAHA was approved by the FDA in 1997 as a synovial fluid replacement device to help relieve the pain associated with knee osteoarthritis (OA) in patients who fail to respond adequately to conservative treatment and simple analgesics. In this study, IAHA, specifically Euflexxa, will be used off-label to determine whether patients afflicted with PFPS will experience similar analgesic effects as seen in those with OA.
Center for Musculoskeletal Care - NYU Langone Medical Center, New York
Collaborators (1)
Ferring Pharmaceuticals
INDUSTRY
NYU Langone Health
OTHER